nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—ABCB11—Rifampicin—leprosy	0.124	0.142	CbGbCtD
Progesterone—ABCC1—Rifampicin—leprosy	0.0877	0.101	CbGbCtD
Progesterone—CYP2A6—Rifampicin—leprosy	0.0634	0.0729	CbGbCtD
Progesterone—CYP1A1—Thalidomide—leprosy	0.056	0.0643	CbGbCtD
Progesterone—CYP3A7—Rifampicin—leprosy	0.0434	0.0498	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.0434	0.0498	CbGbCtD
Progesterone—CYP3A7—Dapsone—leprosy	0.0358	0.0411	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0358	0.0411	CbGbCtD
Progesterone—CYP3A5—Thalidomide—leprosy	0.0336	0.0386	CbGbCtD
Progesterone—CYP3A5—Rifampicin—leprosy	0.0325	0.0374	CbGbCtD
Progesterone—CYP2C8—Rifampicin—leprosy	0.0313	0.036	CbGbCtD
Progesterone—CYP2C19—Thalidomide—leprosy	0.0271	0.0311	CbGbCtD
Progesterone—CYP3A5—Dapsone—leprosy	0.0269	0.0309	CbGbCtD
Progesterone—CYP2C19—Rifampicin—leprosy	0.0262	0.0302	CbGbCtD
Progesterone—CYP2C8—Dapsone—leprosy	0.0258	0.0297	CbGbCtD
Progesterone—CYP1A2—Thalidomide—leprosy	0.025	0.0287	CbGbCtD
Progesterone—CYP1A2—Rifampicin—leprosy	0.0242	0.0278	CbGbCtD
Progesterone—CYP2C9—Thalidomide—leprosy	0.0225	0.0259	CbGbCtD
Progesterone—CYP2C9—Rifampicin—leprosy	0.0218	0.0251	CbGbCtD
Progesterone—CYP2C19—Dapsone—leprosy	0.0217	0.0249	CbGbCtD
Progesterone—ABCB1—Rifampicin—leprosy	0.0212	0.0243	CbGbCtD
Progesterone—CYP2C9—Dapsone—leprosy	0.018	0.0207	CbGbCtD
Progesterone—CYP3A4—Rifampicin—leprosy	0.0127	0.0146	CbGbCtD
Progesterone—CYP3A4—Dapsone—leprosy	0.0105	0.012	CbGbCtD
Progesterone—AR—scrotum—leprosy	0.00571	0.209	CbGeAlD
Progesterone—SHBG—hindlimb—leprosy	0.00271	0.0992	CbGeAlD
Progesterone—Thromboembolism—Thalidomide—leprosy	0.0027	0.0263	CcSEcCtD
Progesterone—Erythema nodosum—Thalidomide—leprosy	0.00198	0.0193	CcSEcCtD
Progesterone—Raised liver function tests—Thalidomide—leprosy	0.00186	0.0181	CcSEcCtD
Progesterone—Transient ischaemic attack—Thalidomide—leprosy	0.0017	0.0166	CcSEcCtD
Progesterone—Embolism venous—Thalidomide—leprosy	0.0017	0.0166	CcSEcCtD
Progesterone—Foetor hepaticus—Thalidomide—leprosy	0.00151	0.0147	CcSEcCtD
Progesterone—Toothache—Thalidomide—leprosy	0.00141	0.0137	CcSEcCtD
Progesterone—Embolism—Thalidomide—leprosy	0.00134	0.013	CcSEcCtD
Progesterone—Tooth disorder—Thalidomide—leprosy	0.00132	0.0129	CcSEcCtD
Progesterone—Galactorrhoea—Thalidomide—leprosy	0.00132	0.0129	CcSEcCtD
Progesterone—Seborrhoeic dermatitis—Thalidomide—leprosy	0.00126	0.0123	CcSEcCtD
Progesterone—Menstrual disorder—Thalidomide—leprosy	0.00126	0.0123	CcSEcCtD
Progesterone—Liver disorder—Thalidomide—leprosy	0.00126	0.0123	CcSEcCtD
Progesterone—Thrombosis—Thalidomide—leprosy	0.00121	0.0118	CcSEcCtD
Progesterone—Metrorrhagia—Thalidomide—leprosy	0.0012	0.0117	CcSEcCtD
Progesterone—PGR—blood vessel—leprosy	0.00117	0.0427	CbGeAlD
Progesterone—Neuritis—Thalidomide—leprosy	0.00115	0.0112	CcSEcCtD
Progesterone—Stupor—Thalidomide—leprosy	0.00115	0.0112	CcSEcCtD
Progesterone—Cholestasis—Thalidomide—leprosy	0.00113	0.011	CcSEcCtD
Progesterone—Nasopharyngitis—Dapsone—leprosy	0.00109	0.0106	CcSEcCtD
Progesterone—CYP1A1—skin epidermis—leprosy	0.00104	0.0379	CbGeAlD
Progesterone—Endocrine disorder—Thalidomide—leprosy	0.00103	0.0101	CcSEcCtD
Progesterone—Acne—Thalidomide—leprosy	0.00102	0.00993	CcSEcCtD
Progesterone—Jaundice cholestatic—Thalidomide—leprosy	0.000976	0.00951	CcSEcCtD
Progesterone—Amenorrhoea—Thalidomide—leprosy	0.000976	0.00951	CcSEcCtD
Progesterone—Accidental injury—Thalidomide—leprosy	0.000969	0.00944	CcSEcCtD
Progesterone—Viral infection—Thalidomide—leprosy	0.000949	0.00925	CcSEcCtD
Progesterone—Skin discolouration—Thalidomide—leprosy	0.000949	0.00925	CcSEcCtD
Progesterone—Hypocalcaemia—Thalidomide—leprosy	0.000937	0.00913	CcSEcCtD
Progesterone—Herpes simplex—Thalidomide—leprosy	0.000931	0.00907	CcSEcCtD
Progesterone—Drug interaction—Thalidomide—leprosy	0.000924	0.00901	CcSEcCtD
Progesterone—Neuropathy peripheral—Dapsone—leprosy	0.000919	0.00895	CcSEcCtD
Progesterone—ESR1—blood vessel—leprosy	0.000911	0.0334	CbGeAlD
Progesterone—Bone pain—Thalidomide—leprosy	0.000895	0.00872	CcSEcCtD
Progesterone—Sinusitis—Dapsone—leprosy	0.000879	0.00857	CcSEcCtD
Progesterone—Gait disturbance—Thalidomide—leprosy	0.000879	0.00856	CcSEcCtD
Progesterone—Pulmonary embolism—Thalidomide—leprosy	0.000858	0.00836	CcSEcCtD
Progesterone—Hepatocellular injury—Thalidomide—leprosy	0.000858	0.00836	CcSEcCtD
Progesterone—NR3C1—nerve—leprosy	0.000856	0.0314	CbGeAlD
Progesterone—Eructation—Thalidomide—leprosy	0.000843	0.00821	CcSEcCtD
Progesterone—Pharyngitis—Dapsone—leprosy	0.000835	0.00814	CcSEcCtD
Progesterone—Depressed level of consciousness—Thalidomide—leprosy	0.000828	0.00807	CcSEcCtD
Progesterone—Cramps of lower extremities—Thalidomide—leprosy	0.000788	0.00768	CcSEcCtD
Progesterone—Tinnitus—Dapsone—leprosy	0.000784	0.00764	CcSEcCtD
Progesterone—Lightheadedness—Thalidomide—leprosy	0.000767	0.00748	CcSEcCtD
Progesterone—Hypertonia—Thalidomide—leprosy	0.000752	0.00732	CcSEcCtD
Progesterone—Mental disability—Thalidomide—leprosy	0.000744	0.00725	CcSEcCtD
Progesterone—Erythema—Dapsone—leprosy	0.000732	0.00714	CcSEcCtD
Progesterone—Lymphadenopathy—Thalidomide—leprosy	0.00073	0.00711	CcSEcCtD
Progesterone—Thrombophlebitis—Thalidomide—leprosy	0.000719	0.00701	CcSEcCtD
Progesterone—Gastroenteritis—Thalidomide—leprosy	0.000702	0.00684	CcSEcCtD
Progesterone—Vascular purpura—Thalidomide—leprosy	0.000696	0.00678	CcSEcCtD
Progesterone—Vision blurred—Dapsone—leprosy	0.00069	0.00672	CcSEcCtD
Progesterone—Injury—Thalidomide—leprosy	0.000677	0.0066	CcSEcCtD
Progesterone—Libido decreased—Thalidomide—leprosy	0.000671	0.00654	CcSEcCtD
Progesterone—Increased appetite—Thalidomide—leprosy	0.000663	0.00646	CcSEcCtD
Progesterone—Vertigo—Dapsone—leprosy	0.000658	0.00641	CcSEcCtD
Progesterone—Visual disturbance—Thalidomide—leprosy	0.000657	0.0064	CcSEcCtD
Progesterone—Purpura—Thalidomide—leprosy	0.000646	0.00629	CcSEcCtD
Progesterone—Arthritis—Thalidomide—leprosy	0.000641	0.00624	CcSEcCtD
Progesterone—Cough—Dapsone—leprosy	0.000639	0.00623	CcSEcCtD
Progesterone—Pain in extremity—Thalidomide—leprosy	0.000623	0.00607	CcSEcCtD
Progesterone—Osteoarthritis—Thalidomide—leprosy	0.000623	0.00607	CcSEcCtD
Progesterone—Diplopia—Thalidomide—leprosy	0.000623	0.00607	CcSEcCtD
Progesterone—Disturbance in sexual arousal—Thalidomide—leprosy	0.000618	0.00602	CcSEcCtD
Progesterone—Affect lability—Thalidomide—leprosy	0.000613	0.00597	CcSEcCtD
Progesterone—Migraine—Thalidomide—leprosy	0.000613	0.00597	CcSEcCtD
Progesterone—Face oedema—Thalidomide—leprosy	0.000601	0.00586	CcSEcCtD
Progesterone—Mood swings—Thalidomide—leprosy	0.00059	0.00575	CcSEcCtD
Progesterone—Tachycardia—Dapsone—leprosy	0.000583	0.00568	CcSEcCtD
Progesterone—SLC10A1—testis—leprosy	0.000581	0.0213	CbGeAlD
Progesterone—Liver function test abnormal—Thalidomide—leprosy	0.000575	0.0056	CcSEcCtD
Progesterone—ABCB11—testis—leprosy	0.000574	0.021	CbGeAlD
Progesterone—SLC10A1—nervous system—leprosy	0.00057	0.0209	CbGeAlD
Progesterone—Breast disorder—Thalidomide—leprosy	0.000563	0.00548	CcSEcCtD
Progesterone—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000561	0.00546	CcSEcCtD
Progesterone—Cramp muscle—Thalidomide—leprosy	0.000561	0.00546	CcSEcCtD
Progesterone—Alanine aminotransferase increased—Thalidomide—leprosy	0.000549	0.00535	CcSEcCtD
Progesterone—SIGMAR1—eye—leprosy	0.000549	0.0201	CbGeAlD
Progesterone—Abdominal distension—Thalidomide—leprosy	0.000542	0.00528	CcSEcCtD
Progesterone—Insomnia—Dapsone—leprosy	0.000541	0.00527	CcSEcCtD
Progesterone—Dysphagia—Thalidomide—leprosy	0.000538	0.00524	CcSEcCtD
Progesterone—Angina pectoris—Thalidomide—leprosy	0.000524	0.00511	CcSEcCtD
Progesterone—CYP1B1—eye—leprosy	0.000522	0.0191	CbGeAlD
Progesterone—Bronchitis—Thalidomide—leprosy	0.000517	0.00504	CcSEcCtD
Progesterone—CYP17A1—testis—leprosy	0.000506	0.0185	CbGeAlD
Progesterone—OPRK1—nervous system—leprosy	0.000502	0.0184	CbGeAlD
Progesterone—Upper respiratory tract infection—Thalidomide—leprosy	0.0005	0.00487	CcSEcCtD
Progesterone—Pollakiuria—Thalidomide—leprosy	0.000497	0.00484	CcSEcCtD
Progesterone—CYP17A1—nervous system—leprosy	0.000497	0.0182	CbGeAlD
Progesterone—Weight increased—Thalidomide—leprosy	0.00049	0.00477	CcSEcCtD
Progesterone—Gastrointestinal pain—Dapsone—leprosy	0.000489	0.00476	CcSEcCtD
Progesterone—Weight decreased—Thalidomide—leprosy	0.000487	0.00474	CcSEcCtD
Progesterone—Hyperglycaemia—Thalidomide—leprosy	0.000485	0.00473	CcSEcCtD
Progesterone—Pneumonia—Thalidomide—leprosy	0.000483	0.0047	CcSEcCtD
Progesterone—Infestation—Thalidomide—leprosy	0.00048	0.00467	CcSEcCtD
Progesterone—Drowsiness—Thalidomide—leprosy	0.00048	0.00467	CcSEcCtD
Progesterone—Infestation NOS—Thalidomide—leprosy	0.00048	0.00467	CcSEcCtD
Progesterone—Depression—Thalidomide—leprosy	0.000478	0.00466	CcSEcCtD
Progesterone—Body temperature increased—Dapsone—leprosy	0.000472	0.0046	CcSEcCtD
Progesterone—Abdominal pain—Dapsone—leprosy	0.000472	0.0046	CcSEcCtD
Progesterone—Neuropathy peripheral—Thalidomide—leprosy	0.00047	0.00458	CcSEcCtD
Progesterone—Conjunctivitis—Thalidomide—leprosy	0.000466	0.00454	CcSEcCtD
Progesterone—CYP1B1—skin of body—leprosy	0.000454	0.0166	CbGeAlD
Progesterone—Sinusitis—Thalidomide—leprosy	0.00045	0.00439	CcSEcCtD
Progesterone—NR3C2—tendon—leprosy	0.000442	0.0162	CbGeAlD
Progesterone—Rhinitis—Thalidomide—leprosy	0.000432	0.00421	CcSEcCtD
Progesterone—Hepatitis—Thalidomide—leprosy	0.000431	0.0042	CcSEcCtD
Progesterone—AR—skin of body—leprosy	0.00043	0.0157	CbGeAlD
Progesterone—Pharyngitis—Thalidomide—leprosy	0.000427	0.00416	CcSEcCtD
Progesterone—Urinary tract disorder—Thalidomide—leprosy	0.000425	0.00414	CcSEcCtD
Progesterone—Oedema peripheral—Thalidomide—leprosy	0.000424	0.00413	CcSEcCtD
Progesterone—Urethral disorder—Thalidomide—leprosy	0.000422	0.00411	CcSEcCtD
Progesterone—Visual impairment—Thalidomide—leprosy	0.000415	0.00404	CcSEcCtD
Progesterone—Erythema multiforme—Thalidomide—leprosy	0.000407	0.00397	CcSEcCtD
Progesterone—Eye disorder—Thalidomide—leprosy	0.000402	0.00392	CcSEcCtD
Progesterone—Tinnitus—Thalidomide—leprosy	0.000402	0.00391	CcSEcCtD
Progesterone—Cardiac disorder—Thalidomide—leprosy	0.0004	0.00389	CcSEcCtD
Progesterone—Angiopathy—Thalidomide—leprosy	0.000391	0.00381	CcSEcCtD
Progesterone—Immune system disorder—Thalidomide—leprosy	0.000389	0.00379	CcSEcCtD
Progesterone—Mediastinal disorder—Thalidomide—leprosy	0.000388	0.00378	CcSEcCtD
Progesterone—Alopecia—Thalidomide—leprosy	0.000381	0.00371	CcSEcCtD
Progesterone—Vomiting—Dapsone—leprosy	0.00038	0.0037	CcSEcCtD
Progesterone—SHBG—testis—leprosy	0.000377	0.0138	CbGeAlD
Progesterone—Mental disorder—Thalidomide—leprosy	0.000377	0.00368	CcSEcCtD
Progesterone—Malnutrition—Thalidomide—leprosy	0.000375	0.00365	CcSEcCtD
Progesterone—Headache—Dapsone—leprosy	0.000374	0.00365	CcSEcCtD
Progesterone—Flatulence—Thalidomide—leprosy	0.000369	0.0036	CcSEcCtD
Progesterone—Tension—Thalidomide—leprosy	0.000368	0.00358	CcSEcCtD
Progesterone—NR3C2—testis—leprosy	0.000366	0.0134	CbGeAlD
Progesterone—Nervousness—Thalidomide—leprosy	0.000364	0.00355	CcSEcCtD
Progesterone—SIGMAR1—tendon—leprosy	0.000363	0.0133	CbGeAlD
Progesterone—Back pain—Thalidomide—leprosy	0.000363	0.00353	CcSEcCtD
Progesterone—Muscle spasms—Thalidomide—leprosy	0.00036	0.00351	CcSEcCtD
Progesterone—ABCB1—blood vessel—leprosy	0.00036	0.0132	CbGeAlD
Progesterone—NR3C2—nervous system—leprosy	0.000359	0.0132	CbGeAlD
Progesterone—NR3C1—eye—leprosy	0.000358	0.0131	CbGeAlD
Progesterone—Nausea—Dapsone—leprosy	0.000355	0.00346	CcSEcCtD
Progesterone—Vision blurred—Thalidomide—leprosy	0.000353	0.00344	CcSEcCtD
Progesterone—Tremor—Thalidomide—leprosy	0.000351	0.00342	CcSEcCtD
Progesterone—Ill-defined disorder—Thalidomide—leprosy	0.000348	0.00339	CcSEcCtD
Progesterone—Anaemia—Thalidomide—leprosy	0.000347	0.00338	CcSEcCtD
Progesterone—CYP1B1—tendon—leprosy	0.000345	0.0127	CbGeAlD
Progesterone—Angioedema—Thalidomide—leprosy	0.000343	0.00334	CcSEcCtD
Progesterone—PGR—testis—leprosy	0.00034	0.0125	CbGeAlD
Progesterone—Malaise—Thalidomide—leprosy	0.000338	0.00329	CcSEcCtD
Progesterone—Vertigo—Thalidomide—leprosy	0.000337	0.00328	CcSEcCtD
Progesterone—Syncope—Thalidomide—leprosy	0.000336	0.00328	CcSEcCtD
Progesterone—PGR—nervous system—leprosy	0.000334	0.0122	CbGeAlD
Progesterone—Palpitations—Thalidomide—leprosy	0.000331	0.00323	CcSEcCtD
Progesterone—Loss of consciousness—Thalidomide—leprosy	0.00033	0.00321	CcSEcCtD
Progesterone—Cough—Thalidomide—leprosy	0.000327	0.00319	CcSEcCtD
Progesterone—AR—tendon—leprosy	0.000327	0.012	CbGeAlD
Progesterone—Convulsion—Thalidomide—leprosy	0.000325	0.00316	CcSEcCtD
Progesterone—Hypertension—Thalidomide—leprosy	0.000324	0.00315	CcSEcCtD
Progesterone—CYP1A1—skin of body—leprosy	0.000321	0.0118	CbGeAlD
Progesterone—SLC22A1—nervous system—leprosy	0.00032	0.0117	CbGeAlD
Progesterone—Chest pain—Thalidomide—leprosy	0.000319	0.00311	CcSEcCtD
Progesterone—Myalgia—Thalidomide—leprosy	0.000319	0.00311	CcSEcCtD
Progesterone—Arthralgia—Thalidomide—leprosy	0.000319	0.00311	CcSEcCtD
Progesterone—Anxiety—Thalidomide—leprosy	0.000318	0.0031	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000317	0.00309	CcSEcCtD
Progesterone—Discomfort—Thalidomide—leprosy	0.000315	0.00307	CcSEcCtD
Progesterone—Dry mouth—Thalidomide—leprosy	0.000312	0.00304	CcSEcCtD
Progesterone—NR3C1—skin of body—leprosy	0.000311	0.0114	CbGeAlD
Progesterone—SLC22A3—testis—leprosy	0.000311	0.0114	CbGeAlD
Progesterone—ABCC1—tendon—leprosy	0.000311	0.0114	CbGeAlD
Progesterone—Confusional state—Thalidomide—leprosy	0.000309	0.00301	CcSEcCtD
Progesterone—Oedema—Thalidomide—leprosy	0.000306	0.00298	CcSEcCtD
Progesterone—SLC22A3—nervous system—leprosy	0.000305	0.0112	CbGeAlD
Progesterone—Infection—Thalidomide—leprosy	0.000304	0.00296	CcSEcCtD
Progesterone—Shock—Thalidomide—leprosy	0.000301	0.00293	CcSEcCtD
Progesterone—SIGMAR1—testis—leprosy	0.000301	0.011	CbGeAlD
Progesterone—Nervous system disorder—Thalidomide—leprosy	0.0003	0.00292	CcSEcCtD
Progesterone—Tachycardia—Thalidomide—leprosy	0.000299	0.00291	CcSEcCtD
Progesterone—Skin disorder—Thalidomide—leprosy	0.000297	0.0029	CcSEcCtD
Progesterone—Hyperhidrosis—Thalidomide—leprosy	0.000296	0.00288	CcSEcCtD
Progesterone—Anorexia—Thalidomide—leprosy	0.000292	0.00284	CcSEcCtD
Progesterone—CYP1B1—testis—leprosy	0.000286	0.0105	CbGeAlD
Progesterone—Hypotension—Thalidomide—leprosy	0.000286	0.00279	CcSEcCtD
Progesterone—CYP1B1—nervous system—leprosy	0.000281	0.0103	CbGeAlD
Progesterone—Musculoskeletal discomfort—Thalidomide—leprosy	0.000279	0.00272	CcSEcCtD
Progesterone—Insomnia—Thalidomide—leprosy	0.000277	0.0027	CcSEcCtD
Progesterone—Paraesthesia—Thalidomide—leprosy	0.000275	0.00268	CcSEcCtD
Progesterone—Dyspnoea—Thalidomide—leprosy	0.000273	0.00266	CcSEcCtD
Progesterone—Somnolence—Thalidomide—leprosy	0.000272	0.00265	CcSEcCtD
Progesterone—AR—testis—leprosy	0.000271	0.00993	CbGeAlD
Progesterone—Dyspepsia—Thalidomide—leprosy	0.000269	0.00262	CcSEcCtD
Progesterone—Decreased appetite—Thalidomide—leprosy	0.000266	0.00259	CcSEcCtD
Progesterone—ESR1—testis—leprosy	0.000266	0.00974	CbGeAlD
Progesterone—AR—nervous system—leprosy	0.000266	0.00974	CbGeAlD
Progesterone—Gastrointestinal disorder—Thalidomide—leprosy	0.000264	0.00257	CcSEcCtD
Progesterone—Fatigue—Thalidomide—leprosy	0.000264	0.00257	CcSEcCtD
Progesterone—Pain—Thalidomide—leprosy	0.000262	0.00255	CcSEcCtD
Progesterone—Constipation—Thalidomide—leprosy	0.000262	0.00255	CcSEcCtD
Progesterone—ESR1—nervous system—leprosy	0.000261	0.00956	CbGeAlD
Progesterone—ABCC1—testis—leprosy	0.000257	0.00943	CbGeAlD
Progesterone—Feeling abnormal—Thalidomide—leprosy	0.000252	0.00246	CcSEcCtD
Progesterone—Gastrointestinal pain—Thalidomide—leprosy	0.00025	0.00244	CcSEcCtD
Progesterone—Urticaria—Thalidomide—leprosy	0.000243	0.00237	CcSEcCtD
Progesterone—Body temperature increased—Thalidomide—leprosy	0.000242	0.00236	CcSEcCtD
Progesterone—Abdominal pain—Thalidomide—leprosy	0.000242	0.00236	CcSEcCtD
Progesterone—NR3C1—tendon—leprosy	0.000237	0.00868	CbGeAlD
Progesterone—Hypersensitivity—Thalidomide—leprosy	0.000225	0.0022	CcSEcCtD
Progesterone—Asthenia—Thalidomide—leprosy	0.00022	0.00214	CcSEcCtD
Progesterone—CYP2C8—testis—leprosy	0.000219	0.00803	CbGeAlD
Progesterone—Pruritus—Thalidomide—leprosy	0.000216	0.00211	CcSEcCtD
Progesterone—Diarrhoea—Thalidomide—leprosy	0.000209	0.00204	CcSEcCtD
Progesterone—Dizziness—Thalidomide—leprosy	0.000202	0.00197	CcSEcCtD
Progesterone—CYP1A1—nervous system—leprosy	0.000198	0.00727	CbGeAlD
Progesterone—NR3C1—testis—leprosy	0.000196	0.00719	CbGeAlD
Progesterone—Vomiting—Thalidomide—leprosy	0.000195	0.0019	CcSEcCtD
Progesterone—Rash—Thalidomide—leprosy	0.000193	0.00188	CcSEcCtD
Progesterone—Dermatitis—Thalidomide—leprosy	0.000193	0.00188	CcSEcCtD
Progesterone—NR3C1—nervous system—leprosy	0.000193	0.00706	CbGeAlD
Progesterone—Headache—Thalidomide—leprosy	0.000192	0.00187	CcSEcCtD
Progesterone—Nausea—Thalidomide—leprosy	0.000182	0.00177	CcSEcCtD
Progesterone—CYP2D6—testis—leprosy	0.000146	0.00535	CbGeAlD
Progesterone—CYP3A4—nervous system—leprosy	0.000146	0.00534	CbGeAlD
Progesterone—CYP2D6—nervous system—leprosy	0.000143	0.00525	CbGeAlD
Progesterone—ABCB1—testis—leprosy	0.000105	0.00385	CbGeAlD
Progesterone—ABCB1—nervous system—leprosy	0.000103	0.00378	CbGeAlD
